Top

Published in:

01-09-2017 | Case report

Tocilizumab

Infusion related reaction: case report

Published in: Reactions Weekly | Issue 1/2017

Excerpt

In a study, a patient [age and sex not stated] developed infusion related reaction during administration of tocilizumab for rheumatoid arthritis [dosage, time to reaction onset and outcome not stated]. The drug discontinuation due to the infusion reaction was not required. …

Santoro M, et al. Biological drugs: Assessment and analysis of the reasons that induced the discontinuation of therapy in patients with Polyarthritis. [Italian]. Giornale Italiano di Farmacia Clinica 31: 54-62, No. 2, 2017. Available from: URL: http://doi.org/10.1721/2716.27719 [Italian; summarised from a translation] - Italy

Title: Tocilizumab
Infusion related reaction: case report
Publication date: 01-09-2017
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2017
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-017-35873-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Tocilizumab

Infusion related reaction: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2017

Nintedanib/pirfenidone

Doxycycline hyclate

Nitrogen

Ropinirole

Methadone overdose

Gemcitabine